Home Pharmaceutics CRISPR’s cardio catch-all drives a biotech’s broad potential

CRISPR’s cardio catch-all drives a biotech’s broad potential

by Newsroom


This audio is auto-generated. Please let us know if you have feedback.

Welcome to Biotech Spotlight, a series featuring companies creating breakthrough technologies and products. Today, we’re looking at Scribe Therapeutics, which is using CRISPR-based technology to target risk factors for the most common cause of death:…



Source link

You may also like

About Us

Pharma Newswire™ aggregates, publishes and distributes news in the Pharmaceutical Industry. In association with EmailWire, Pharma Newswire™ provides press release distribution services in the pharmaceutical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. To send a press release, contact us through the following messaging apps:

Pharma Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC